154 related articles for article (PubMed ID: 22130699)
1. Extracorporeal assays of thrombosis.
Badimon L; Padro T; Vilahur G
Methods Mol Biol; 2012; 788():43-57. PubMed ID: 22130699
[TBL] [Abstract][Full Text] [Related]
2. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
Suades R; Padró T; Vilahur G; Badimon L
Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects.
Vilahur G; Baldellou MI; Segalés E; Salas E; Badimon L
Cardiovasc Res; 2004 Mar; 61(4):806-16. PubMed ID: 14985078
[TBL] [Abstract][Full Text] [Related]
4. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
Vilahur G; Segalés E; Salas E; Badimon L
Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
[TBL] [Abstract][Full Text] [Related]
5. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
[TBL] [Abstract][Full Text] [Related]
6. A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall--studies in a porcine model.
Badimon L; Martínez-González J; Royo T; Lassila R; Badimon JJ
Thromb Haemost; 1999 Dec; 82(6):1736-42. PubMed ID: 10613663
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model.
Badimon L; Badimon JJ
J Clin Invest; 1989 Oct; 84(4):1134-44. PubMed ID: 2794050
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal model for study of factors affecting thrombus formation.
Benis AM; Nossel HL; Aledort LM; Koffsky RM; Stevenson JF; Leonard EF; Shiang H; Litwak RS
Thromb Diath Haemorrh; 1975 Sep; 34(1):127-44. PubMed ID: 1103356
[TBL] [Abstract][Full Text] [Related]
9. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
10. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
[TBL] [Abstract][Full Text] [Related]
11. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi.
Badimon L; Chesebro JH; Badimon JJ
Circulation; 1992 Dec; 86(6 Suppl):III74-85. PubMed ID: 1424053
[TBL] [Abstract][Full Text] [Related]
12. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.
Badimon JJ; Lettino M; Toschi V; Fuster V; Berrozpe M; Chesebro JH; Badimon L
Circulation; 1999 Apr; 99(14):1780-7. PubMed ID: 10199872
[TBL] [Abstract][Full Text] [Related]
13. Macrophage metabolism in atherosclerosis.
Bories GFP; Leitinger N
FEBS Lett; 2017 Oct; 591(19):3042-3060. PubMed ID: 28796886
[TBL] [Abstract][Full Text] [Related]
14. Badimon Perfusion Chamber: An Ex Vivo Model of Thrombosis.
Zafar MU; Santos-Gallego CG; Badimon L; Badimon JJ
Methods Mol Biol; 2018; 1816():161-171. PubMed ID: 29987818
[TBL] [Abstract][Full Text] [Related]
15. Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood.
Badimon L; Badimon JJ; Rand J; Turitto VT; Fuster V
J Lab Clin Med; 1987 Nov; 110(5):634-47. PubMed ID: 3312444
[TBL] [Abstract][Full Text] [Related]
16. Porcine von Willebrand disease: implications for the pathophysiology of atherosclerosis and thrombosis.
Fuster V; Griggs TR
Prog Hemost Thromb; 1986; 8():159-83. PubMed ID: 3550894
[TBL] [Abstract][Full Text] [Related]
17. Increased platelet deposition on atherosclerotic coronary arteries.
van Zanten GH; de Graaf S; Slootweg PJ; Heijnen HF; Connolly TM; de Groot PG; Sixma JJ
J Clin Invest; 1994 Feb; 93(2):615-32. PubMed ID: 8113399
[TBL] [Abstract][Full Text] [Related]
18. Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia.
Li M; Chen J; Li YS; Feng YB; Gu X; Shi CZ
Int J Cardiol; 2006 Jan; 106(2):285-8. PubMed ID: 16183151
[TBL] [Abstract][Full Text] [Related]
19. Platelet structural physiology: the ultrastructure of adhesion, secretion, and aggregation in arterial thrombosis.
White JG
Cardiovasc Clin; 1987; 18(1):13-33. PubMed ID: 3607810
[TBL] [Abstract][Full Text] [Related]
20. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Vilahur G; Casaní L; Badimon L
Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
